0001884363-24-000001.txt : 20241031
0001884363-24-000001.hdr.sgml : 20241031
20241031134240
ACCESSION NUMBER: 0001884363-24-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20241031
DATE AS OF CHANGE: 20241031
EFFECTIVENESS DATE: 20241031
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Garuda Therapeutics, Inc.
CENTRAL INDEX KEY: 0001884363
ORGANIZATION NAME:
IRS NUMBER: 863018867
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-528326
FILM NUMBER: 241414440
BUSINESS ADDRESS:
STREET 1: 22 STRATHMORE ROAD
STREET 2: SUITE 414
CITY: NATICK
STATE: MA
ZIP: 02467
BUSINESS PHONE: 617-851-4586
MAIL ADDRESS:
STREET 1: 22 STRATHMORE ROAD
STREET 2: SUITE 414
CITY: NATICK
STATE: MA
ZIP: 02467
D
1
primary_doc.xml
X0708
D
LIVE
0001884363
Garuda Therapeutics, Inc.
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
617-851-4586
DELAWARE
None
None
Corporation
true
2021
Eric
Aguiar
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
Director
Steve
Liapis
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
Director
Carl
Gordon
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
Director
Raymond
Kelleher
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
Director
Adam
Craig
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Director
Rahul
Singhvi
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
Director
Geoff
Meyerson
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
Director
David
Kirske
215 First Street
Suite 340-350
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2024-10-17
false
true
true
false
0
Indefinite
47709955
Indefinite
false
16
0
0
0
false
Garuda Therapeutics, Inc.
/s/ Adam Craig
Adam Craig
President and CEO
2024-10-31